PC
MDCO

PointState Capital’s Medicines Co MDCO Stock Holding History

PointState Capital’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,929,476
Closed -$87.6M – 155
2018
Q3 		$87.6M Sell
2,929,476
-1,083,014
-27% -$40.8M 1.15% 27
2018
Q2 		$147M Buy
4,012,490
+306,343
+8% +$9.95M 1.67% 18
2018
Q1 		$122M Buy
3,706,147
+1,663,694
+81% +$52M 1.33% 27
2017
Q4 		$55.8M Buy
2,042,453
+361,208
+21% +$11.1M 0.54% 50
2017
Q3 		$62.3M Buy
1,681,245
+577,279
+52% +$21.3M 0.53% 46
2017
Q2 		$42M Buy
1,103,966
+8,866
+0.8% +$395K 0.46% 54
2017
Q1 		$53.5M Buy
+1,095,100
New +$49.9M 0.56% 46
2016
Q2 		– Sell
-280,000
Closed -$8.9M – 142
2016
Q1 		$8.9M Sell
280,000
-722,000
-72% -$23.6M 0.24% 44
2015
Q4 		$37.4M Sell
1,002,000
-1,036,541
-51% -$39.2M 0.95% 21
2015
Q3 		$77.4M Sell
2,038,541
-636,459
-24% -$22.3M 2.16% 13
2015
Q2 		$76.5M Buy
2,675,000
+250,072
+10% +$6.97M 0.89% 29
2015
Q1 		$67.9M Sell
2,424,928
-950,412
-28% -$26.7M 0.92% 29
2014
Q4 		$93.4M Buy
3,375,340
+1,334,756
+65% +$33.1M 1.59% 25
2014
Q3 		$45.5M Sell
2,040,584
-1,427,730
-41% -$36.3M 0.83% 28
2014
Q2 		$101M Buy
3,468,314
+1,091,900
+46% +$29.2M 1.27% 19
2014
Q1 		$67.5M Buy
2,376,414
+1,476,414
+164% +$48.9M 1.07% 27
2013
Q4 		$34.8M Sell
900,000
-1,450,000
-62% -$51.8M 0.44% 52
2013
Q3 		$78.8M Buy
2,350,000
+689,200
+41% +$22M 1.35% 19
2013
Q2 		$51.1M Buy
+1,660,800
New +$55.6M 0.88% 30

Other funds holding MDCO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $150M AUM 17.71% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

PointState Capital's MDCO Position: Q4 2018 in Review

PointState Capital sold out of Medicines Co (MDCO) in Q4 2018, closing a stake of 2,929,476 shares — an estimated $87.6M sold.

PointState Capital first reported a position in MDCO in Q2 2013 and held it in 19 quarters. The position peaked at $147M in Q2 2018. 188 funds tracked by Wall St. Rank hold MDCO as of Q4 2018.

  • PointState Capital reported no remaining Medicines Co position as of Q4 2018 after selling out during the quarter.
  • PointState Capital sold 2,929,476 Medicines Co shares in Q4 2018, an estimated $87.6M.
  • PointState Capital first reported a position in Medicines Co in Q2 2013 and held it in 19 quarters.
  • PointState Capital's Medicines Co position peaked at $147M in Q2 2018.
  • 188 funds tracked by Wall St. Rank held Medicines Co as of Q4 2018.

Based on PointState Capital's 13F filing for Q4 2018, filed 14 Feb 2019.